New Zealand markets closed

Madrigal Pharmaceuticals, Inc. (MDGL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
220.06+2.89 (+1.33%)
At close: 04:00PM EDT
220.06 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-444,275
-373,630
-295,350
-241,846
-202,244
Depreciation & amortisation
571
527
467
405
471
Stock-based compensation
58,387
49,735
31,625
26,873
20,730
Change in working capital
-6,639
-3,276
37,604
30,651
23,482
Accounts payable
4,400
4,210
2,451
20,363
-161
Other working capital
-391,121
-325,709
-225,074
-184,126
-157,895
Other non-cash items
2,636
2,414
797
-
-
Net cash provided by operating activities
-389,320
-324,230
-224,857
-183,917
-157,561
Cash flows from investing activities
Investments in property, plant and equipment
-1,801
-1,479
-217
-209
-334
Purchases of investments
-719,814
-834,439
-143,478
-394,120
-329,342
Sales/maturities of investments
504,012
333,398
350,381
389,274
489,456
Net cash used for investing activities
-217,603
-502,520
206,686
-5,055
159,780
Cash flows from financing activities
Common stock issued
571,748
260,187
255,382
170,207
4,421
Other financing activities
-
-363
-886
-
-
Net cash used provided by (used for) financing activities
1,116,132
595,116
313,451
171,237
5,088
Net change in cash
509,209
-231,634
295,280
-17,735
7,307
Cash at beginning of period
113,308
331,549
36,269
54,004
46,697
Cash at end of period
622,517
99,915
331,549
36,269
54,004
Free cash flow
Operating cash flow
-389,320
-324,230
-224,857
-183,917
-157,561
Capital expenditure
-1,801
-1,479
-217
-209
-334
Free cash flow
-391,121
-325,709
-225,074
-184,126
-157,895